The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
2021 · npj Breast Cancer · 257 citations
https://doi.org/10.1038/s41523-021-00346-1
S
Sheeba Irshad
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
269
Papers
3.1K
Citations
25
h-index
44
i10-index
Sheeba Irshad is an academic researcher from Bacha Khan University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & HER2/EGFR in Cancer Research & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 25, co-authored 229 publications.
ORCID: 0000-0002-4419-7162Papers by this author
worksPitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
2020 · npj Breast Cancer · 198 citations
https://doi.org/10.1038/s41523-020-0156-0
Risk of COVID-19 death in cancer patients: an analysis from Guy’s Cancer Centre and King’s College Hospital in London
2021 · British Journal of Cancer · 57 citations
https://doi.org/10.1038/s41416-021-01500-z
Pitfalls in machine learning‐based assessment of tumor‐infiltrating lymphocytes in breast cancer: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer
2023 · The Journal of Pathology · 46 citations
https://doi.org/10.1002/path.6155
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer
2023 · The Journal of Pathology · 45 citations
https://doi.org/10.1002/path.6165
Clinico-pathologic features, treatment and outcomes of breast cancer during pregnancy or the post-partum period
2020 · Breast Cancer Research and Treatment · 29 citations
https://doi.org/10.1007/s10549-020-05585-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat